Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT02324907 |
Other study ID # |
Pro00055335 |
Secondary ID |
|
Status |
Completed |
Phase |
|
First received |
|
Last updated |
|
Start date |
January 28, 2015 |
Est. completion date |
January 9, 2023 |
Study information
Verified date |
March 2022 |
Source |
Duke University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
The purpose of this study is to determine the clinical efficacy of a novel dynamic
compression intramedullary nail for tibiotalocalcaneal (TTC) arthrodesis.
Description:
This proposal is a collaborative effort of MedShape. This is a prospective investigation to
assess the clinical outcomes of patients with a tibiotalocalcaneal arthrodesis with the
Dynamic Compression Intramedullary Nail (DynaNail). We are planning on enrolling 30 patients.
The assignment of the device is at the discretion of the standard of care provider, not the
study investigator.
Patients with end-stage tibiotalar (ankle) and talocalcaneal (subtalar) joint arthritis from
any etiology will be asked to enroll in the study. After informed consent, the patients will
be asked to complete the following patient reported outcomes questionnaires (standard of care
for all patients in the Foot and Ankle section): 100mm VAS for pain, Short form-36 (SF-36),
and the Foot and Ankle Ability Measure (FAAM). After informed consent, they will then be
scheduled for surgery in a routine fashion. REDCap database will be used to allow on-line
data entry.
The following surgical procedure steps and follow-ups are standard of care at Duke
University. The surgical procedure will involve both tibiotalar and talocalcaneal joint
preparation through any approach (lateral, posterior, anterior with sinus tarsi). The use of
supplemental bone graft is at the discretion of the treating surgeon but must be documented.
The MedShape DynaNail will then be inserted according to the manufacturer's technique. The
patient will be placed in a short leg splint and kept non-weight bearing. The patient will be
discharged from the hospital when medically ready and follow-up in two weeks.
At two weeks, the patient will return to clinic for a standard of care visit and their splint
will be removed. A non-weight bearing lateral radiograph of the hind foot will be taken to
assess the amount of travel of the compressive element. This radiograph is not standard of
care. The patient will be placed in a non-weight bearing cast. The patient will then be asked
to return in two weeks (4 weeks post-operatively). This visit is not standard of care. At
this time another non-weight bearing lateral radiograph will be taken to assess the amount of
travel of the compressive element. The patient will be asked to return at 6 weeks, 3 months,
6 months, 12 months, and 24 months after surgery as is standard of care for this surgery. At
3 months, a CT scan will be obtained to assess healing. This is standard of care at Duke
University. At each of these time-points, the same patient specific outcome questionnaires
will be administered. For any non- standard of care radiographs patients will be asked to
take a urine pregnancy test prior to any radiographs being taken.
Patients will be identified in the clinic by an attending orthopaedic foot and ankle surgeon
or his physician assistant based on clinical exam and radiographic findings. Inclusion
criteria include anyone over age 18 who has ankle and subtalar arthritis and has failed
nonoperative management. Typically, these patients have multiple medical comorbidities and
therefore the only exclusion criteria will be patients who are not healthy enough to undergo
surgery. Patients of all racial, religious, and cultural backgrounds will be included in this
study. Approximately 30 patients will be recruited for the study.